Literature DB >> 2547225

Spontaneous exploration of a 6-arm radial tunnel maze by basal forebrain lesioned rats: effects of the benzodiazepine receptor antagonist beta-carboline ZK 93 426.

M Sarter1, T Steckler.   

Abstract

Nine days following ibotenic acid induced basal forebrain lesions or a sham-operation, rats were allowed to explore an automated six-arm radial tunnel maze. From each session, several measures of locomotor and exploratory activity were registered. Lesioned and sham-operated animals were treated with either the benzodiazepine receptor antagonist beta-carboline ZK 93 426 (5 mg/kg; IP) or vehicle (Cremofor EL 10% in saline; IP; n = 10 for each group). Treatment was carried out 30 min before each session during acquisition (seven sessions) and reversals of the maze configuration (seven sessions). Eight days following the 14th session, the animals were retested without any further drug treatment. The main results suggest that the lesion resulted in locomotor hyperactivity, an increase in the number of blind arm entries, and of choice stereotypy. Treatment with ZK 93 426 attenuated the lesion-induced alterations of locomotor and exploratory activities. During the retest, the lesioned, previously vehicle-treated rats revisited arms which they had already explored during this session more frequently than the lesioned, previously ZK-treated rats; the latter group did not differ from the sham-lesioned controls. It is concluded that basal forebrain lesioned animals explored the tunnel maze less efficiently than sham-lesioned controls and that the lesioned animals benefited from the treatment with ZK 93 426. Although the specificity of the lesion in terms of destruction of cholinergic neurons remains unsettled, and although the psychological significances of the behavioral measures obtained from the tunnel maze are not yet fully understood, these results suggest that antagonists or partial inverse agonists at the benzodiazepine receptor may be able to normalize basal forebrain lesion-induced behavioral alterations.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547225     DOI: 10.1007/BF00444691

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  31 in total

Review 1.  Disinhibitory properties of beta-carboline antagonists of benzodiazepine receptors: a possible therapeutic approach for senile dementia?

Authors:  M Sarter; D N Stephens
Journal:  Biochem Soc Trans       Date:  1989-02       Impact factor: 5.407

2.  Place navigation in rats is impaired by lesions of medial septum and diagonal band but not nucleus basalis magnocellularis.

Authors:  J J Hagan; J D Salamone; J Simpson; S D Iversen; R G Morris
Journal:  Behav Brain Res       Date:  1988-01       Impact factor: 3.332

3.  Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats.

Authors:  S B Dunnett
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

4.  Cholinergic receptor blockade produces impairments in a sensorimotor subsystem for place navigation in the rat: evidence from sensory, motor, and acquisition tests in a swimming pool.

Authors:  I Q Whishaw; J A Tomie
Journal:  Behav Neurosci       Date:  1987-10       Impact factor: 1.912

5.  Enhancement of learning and memory in mice by a benzodiazepine antagonist.

Authors:  H Lal; B Kumar; M J Forster
Journal:  FASEB J       Date:  1988-08       Impact factor: 5.191

6.  Behavioural, biochemical and histochemical effects of different neurotoxic amino acids injected into nucleus basalis magnocellularis of rats.

Authors:  S B Dunnett; I Q Whishaw; G H Jones; S T Bunch
Journal:  Neuroscience       Date:  1987-02       Impact factor: 3.590

7.  The effects of long-term nicotine treatment on locomotion, exploration and memory in young and old rats.

Authors:  H Welzl; B Alessandri; R Oettinger; K Bätig
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

8.  Attenuation of scopolamine-induced impairment of spontaneous alteration behaviour by antagonist but not inverse agonist and agonist beta-carbolines.

Authors:  M Sarter; G Bodewitz; D N Stephens
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

9.  Profound disturbances of spontaneous and learned behaviors following lesions of the nucleus basalis magnocellularis in the rat.

Authors:  B Dubois; W Mayo; Y Agid; M Le Moal; H Simon
Journal:  Brain Res       Date:  1985-07-15       Impact factor: 3.252

10.  Disruption of central cholinergic systems in the rat by basal forebrain lesions or atropine: effects on feeding, sensorimotor behaviour, locomotor activity and spatial navigation.

Authors:  I Q Whishaw; W T O'Connor; S B Dunnett
Journal:  Behav Brain Res       Date:  1985 Sep-Oct       Impact factor: 3.332

View more
  8 in total

Review 1.  Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part I.

Authors:  M Sarter; J Hagan; P Dudchenko
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Effects of cholinergic and non-cholinergic drugs on visual discrimination and delayed visual discrimination performance in rats.

Authors:  J S Andrews; M Grützner; D N Stephens
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 3.  Activating the damaged basal forebrain cholinergic system: tonic stimulation versus signal amplification.

Authors:  M Sarter; J P Bruno; P Dudchenko
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  Effects of ZK 93426 on muscarinic and nicotinic antagonist or nucleus basalis lesioning-induced electrocortical slowing.

Authors:  P Riekkinen; M Riekkinen; J Sirviö; P Riekkinen
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Trans-synaptic stimulation of cortical acetylcholine release after partial 192 IgG-saporin-induced loss of cortical cholinergic afferents.

Authors:  J Fadel; H Moore; M Sarter; J P Bruno
Journal:  J Neurosci       Date:  1996-10-15       Impact factor: 6.167

6.  MDL 26,479: a potential cognition enhancer with benzodiazepine inverse agonist-like properties.

Authors:  J A Miller; M W Dudley; J H Kehne; S M Sorensen; J M Kane
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

7.  Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands.

Authors:  J McGaughy; M Sarter
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

8.  Dissociation between the attentional effects of infusions of a benzodiazepine receptor agonist and an inverse agonist into the basal forebrain.

Authors:  L A Holley; J Turchi; C Apple; M Sarter
Journal:  Psychopharmacology (Berl)       Date:  1995-07       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.